BAZ2A (bromodomain adjacent to zinc finger domain 2A) is a regulatory subunit of ATP-dependent chr12 remodeling complexes that plays crucial roles in gene regulation through multiple mechanisms. BAZ2A functions as part of the NoRC-1 and NoRC-5 ISWI chr12 remodeling complexes, which facilitate nucleosome spacing and chr12 accessibility during DNA-templated processes 1. The protein contains a bromodomain that recognizes acetylated histones and an RNA-binding TAM domain that enables formation of phase-separated nuclear bodies dependent on RNA transcription 2. In prostate cancer, BAZ2A mediates gene repression through RNA-dependent interactions with TOP2A and KDM1A, targeting genes frequently silenced in metastatic disease 3. The protein demonstrates oncogenic properties, with high expression associated with poor prognosis across multiple cancer types and promotion of cell migration, invasion, and proliferation 4. BAZ2A nuclear bodies contact repressive H3K27me3 domains, and disruption of these bodies leads to gene upregulation 2. Chemical probes targeting BAZ2A's bromodomain have been developed for therapeutic applications, though bromodomain inhibition alone may not fully recapitulate BAZ2A's cellular functions 56.